Receptor activator of nuclear factor κb ligand is a novel inducer of tissue factor in macrophages

Jihye Kim, Jeong Ki Min, Jeong Ae Park, Hyun Ju Doh, Yeon Sook Choi, Jaerang Rho, Young Myeong Kim, Young-Guen Kwon

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Rationale: Although recent studies have suggested a role for the receptor activator of nuclear factor κB ligand (RANKL) in the late stages of atherosclerosis (eg, plaque destabilization and rupture), the underlying mechanisms and subsequent events are unclear. Objective: Because blood clotting is common after plaque rupture, we hypothesized that RANKL influenced tissue factor (TF) expression and activity to initiate the coagulation cascade. Methods and Results: RANKL increased the TF mRNA level and procoagulant activity in macrophages, as determined by semiquantitative reverse transcription polymerase chain reaction (semiquantitative RT-PCR) and a chromogenic assay. TF promoter analysis revealed that AP-1 and Egr-1 are responsible for RANKL-induced TF transcription. In addition, RANKL increased phosphorylation of c-Jun NH 2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)1/2. RANKL-induced TF expression was attenuated by JNK- and MEK1-specific inhibitors and by small interfering RNA knockdown of c-Jun and Egr-1. Conclusion: Our results indicate that RANKL induces TF in macrophages mainly through the cooperative action of AP-1 and Egr-1 via JNK and ERK1/2 pathways. These findings provide strong mechanistic support for the role of RANKL in the thrombogenicity of atherosclerotic plaques.

Original languageEnglish
Pages (from-to)871-876
Number of pages6
JournalCirculation Research
Volume107
Issue number7
DOIs
Publication statusPublished - 2010 Oct 1

Fingerprint

Thromboplastin
Cytoplasmic and Nuclear Receptors
Macrophages
Ligands
Phosphotransferases
Transcription Factor AP-1
Rupture
Mitogen-Activated Protein Kinase 3
MAP Kinase Signaling System
Mitogen-Activated Protein Kinase 1
Blood Coagulation
Atherosclerotic Plaques
Small Interfering RNA
Statistical Factor Analysis
Reverse Transcription
Atherosclerosis
Phosphorylation
Polymerase Chain Reaction
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Kim, Jihye ; Min, Jeong Ki ; Park, Jeong Ae ; Doh, Hyun Ju ; Choi, Yeon Sook ; Rho, Jaerang ; Kim, Young Myeong ; Kwon, Young-Guen. / Receptor activator of nuclear factor κb ligand is a novel inducer of tissue factor in macrophages. In: Circulation Research. 2010 ; Vol. 107, No. 7. pp. 871-876.
@article{c13ae63b451c4e83b8a20fa8e140143a,
title = "Receptor activator of nuclear factor κb ligand is a novel inducer of tissue factor in macrophages",
abstract = "Rationale: Although recent studies have suggested a role for the receptor activator of nuclear factor κB ligand (RANKL) in the late stages of atherosclerosis (eg, plaque destabilization and rupture), the underlying mechanisms and subsequent events are unclear. Objective: Because blood clotting is common after plaque rupture, we hypothesized that RANKL influenced tissue factor (TF) expression and activity to initiate the coagulation cascade. Methods and Results: RANKL increased the TF mRNA level and procoagulant activity in macrophages, as determined by semiquantitative reverse transcription polymerase chain reaction (semiquantitative RT-PCR) and a chromogenic assay. TF promoter analysis revealed that AP-1 and Egr-1 are responsible for RANKL-induced TF transcription. In addition, RANKL increased phosphorylation of c-Jun NH 2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)1/2. RANKL-induced TF expression was attenuated by JNK- and MEK1-specific inhibitors and by small interfering RNA knockdown of c-Jun and Egr-1. Conclusion: Our results indicate that RANKL induces TF in macrophages mainly through the cooperative action of AP-1 and Egr-1 via JNK and ERK1/2 pathways. These findings provide strong mechanistic support for the role of RANKL in the thrombogenicity of atherosclerotic plaques.",
author = "Jihye Kim and Min, {Jeong Ki} and Park, {Jeong Ae} and Doh, {Hyun Ju} and Choi, {Yeon Sook} and Jaerang Rho and Kim, {Young Myeong} and Young-Guen Kwon",
year = "2010",
month = "10",
day = "1",
doi = "10.1161/CIRCRESAHA.110.221168",
language = "English",
volume = "107",
pages = "871--876",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

Receptor activator of nuclear factor κb ligand is a novel inducer of tissue factor in macrophages. / Kim, Jihye; Min, Jeong Ki; Park, Jeong Ae; Doh, Hyun Ju; Choi, Yeon Sook; Rho, Jaerang; Kim, Young Myeong; Kwon, Young-Guen.

In: Circulation Research, Vol. 107, No. 7, 01.10.2010, p. 871-876.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Receptor activator of nuclear factor κb ligand is a novel inducer of tissue factor in macrophages

AU - Kim, Jihye

AU - Min, Jeong Ki

AU - Park, Jeong Ae

AU - Doh, Hyun Ju

AU - Choi, Yeon Sook

AU - Rho, Jaerang

AU - Kim, Young Myeong

AU - Kwon, Young-Guen

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Rationale: Although recent studies have suggested a role for the receptor activator of nuclear factor κB ligand (RANKL) in the late stages of atherosclerosis (eg, plaque destabilization and rupture), the underlying mechanisms and subsequent events are unclear. Objective: Because blood clotting is common after plaque rupture, we hypothesized that RANKL influenced tissue factor (TF) expression and activity to initiate the coagulation cascade. Methods and Results: RANKL increased the TF mRNA level and procoagulant activity in macrophages, as determined by semiquantitative reverse transcription polymerase chain reaction (semiquantitative RT-PCR) and a chromogenic assay. TF promoter analysis revealed that AP-1 and Egr-1 are responsible for RANKL-induced TF transcription. In addition, RANKL increased phosphorylation of c-Jun NH 2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)1/2. RANKL-induced TF expression was attenuated by JNK- and MEK1-specific inhibitors and by small interfering RNA knockdown of c-Jun and Egr-1. Conclusion: Our results indicate that RANKL induces TF in macrophages mainly through the cooperative action of AP-1 and Egr-1 via JNK and ERK1/2 pathways. These findings provide strong mechanistic support for the role of RANKL in the thrombogenicity of atherosclerotic plaques.

AB - Rationale: Although recent studies have suggested a role for the receptor activator of nuclear factor κB ligand (RANKL) in the late stages of atherosclerosis (eg, plaque destabilization and rupture), the underlying mechanisms and subsequent events are unclear. Objective: Because blood clotting is common after plaque rupture, we hypothesized that RANKL influenced tissue factor (TF) expression and activity to initiate the coagulation cascade. Methods and Results: RANKL increased the TF mRNA level and procoagulant activity in macrophages, as determined by semiquantitative reverse transcription polymerase chain reaction (semiquantitative RT-PCR) and a chromogenic assay. TF promoter analysis revealed that AP-1 and Egr-1 are responsible for RANKL-induced TF transcription. In addition, RANKL increased phosphorylation of c-Jun NH 2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)1/2. RANKL-induced TF expression was attenuated by JNK- and MEK1-specific inhibitors and by small interfering RNA knockdown of c-Jun and Egr-1. Conclusion: Our results indicate that RANKL induces TF in macrophages mainly through the cooperative action of AP-1 and Egr-1 via JNK and ERK1/2 pathways. These findings provide strong mechanistic support for the role of RANKL in the thrombogenicity of atherosclerotic plaques.

UR - http://www.scopus.com/inward/record.url?scp=77958010783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958010783&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.110.221168

DO - 10.1161/CIRCRESAHA.110.221168

M3 - Article

C2 - 20671239

AN - SCOPUS:77958010783

VL - 107

SP - 871

EP - 876

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 7

ER -